Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Farnesoid X receptor activation inhibits pancreatic carcinogenesis

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2023)10.1016/j.bbadis.2023.166811Source: DataRank Database

Farnesoid X receptor activation inhibits pancreatic carcinogenesis is a research paper published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.91)OA: hybridTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Zhenhua Huang ORCID,Yifan Zhang ORCID,Haitao Sun ORCID,Ulf Hinz ORCID,Ulrike Heger ORCID

Live enrichment

PubMed:37515840 PMC:PMC10935600 OpenAlex:https://openalex.org/W4385323068

Bundesministerium für Bildung und Forschung

Grant: 01GS08114

Bundesministerium für Bildung und Forschung

Grant: 01ZX1305C

Intramural NIH HHS

Grant: Z01 BC005561

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

China Scholarship Council

Jiangsu University

Heidelberger Stiftung Chirurgie

National Cancer Institute

Deutsche Forschungsgemeinschaft

FWCI

0.91

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bbadis.2023.166811

publisherhttps://doi.org/10.1016/j.bbadis.2023.166811

publisherhttps://api.elsevier.com/content/article/PII:S0925443923001771?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0925443923001771?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37515840

Fields of Study

Pancreatic and Hepatic Oncology ResearchDrug Transport and Resistance MechanismsPediatric Hepatobiliary Diseases and Treatments03 medical and health sciences0302 clinical medicineHumansMiceAnimalsPancreasPancreatic NeoplasmsCarcinogenesisCarcinoma, Pancreatic DuctalCell Transformation, NeoplasticChenodeoxycholic AcidBile Acids and Salts

MeSH Terms

AnimalsBile Acids and SaltsCell Transformation, NeoplasticChenodeoxycholic AcidHumansPancreasPancreatic NeoplasmsCarcinoma, Pancreatic DuctalMiceCarcinogenesis

Keywords

Farnesoid X receptorPancreatic Intraepithelial NeoplasiaCancer researchCarcinogenesisPancreatic cancerInternal medicineAutophagyEndocrinologyAcinar cellNuclear receptorBiologyPancreasMedicineCancerApoptosisTranscription factorBile acidPancreatic Ductal AdenocarcinomaPancreatic CarcinogenesisPancreatic NeoplasmsBile Acids and SaltsMiceCell Transformation, NeoplasticHumansAnimalsChenodeoxycholic AcidCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being